Skip to content

Clinical trial to detect diabetic retinopathy.

An Open label Clinical Study to Determine the Specificity and Sensitivity of Algorithm (Software) developed by Bosch using Bosch Mobile non-mydriatic fundus camera comparing it with mydriatic 7-Standard Field Stereoscopic Digital Color Fundus Photography(EDTRS) done in patients with undiagnosed diabetic retinopathy(Symptomatic/asymptomatic) - TI-CT-01-2016

Status
Recruiting
Phases
Phase 3
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/01/007709
Enrollment
550
Registered
2017-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient suffering from diabetes mellitus type 1 or type 2 at least for 5 years from time of screening

Interventions

None listed

Sponsors

Bosch India
Lead Sponsor
Think i Unit of Tenet Health Edutech Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Ready to sign informed consent form 2. Patients with age of 18 years and above 3. Patient suffering from diabetes mellitus type 1 or type 2 at least for 5 years from time of screening 4. Both male and female patients can be enrolled

Exclusion criteria

Exclusion criteria: 1. Subjects with unknown history of diabetes mellitus 2. Subjects with known history of DR 3. Potential subject cannot understand study or informed consent 4. A history of retinal vascular disease other than due to diabetic retinopathy, glaucoma, or other disease that may affect the appearance of the retina or optic disc 5. Other than cataract surgery, history of intraocular surgery, ocular laser treatments for any retinal disease, or ocular injections for diabetic macular edema or proliferative disease 6. Extreme small pupil for image capturing 7. A media opacity in either eye that is severe enough to preclude good retinal photography 8. Subjects with conjunctivitis, red eye or any other inflammatory condition with photophobia. 9. Subjects with gestational DM. 10. If only unilateral retinal image is available. 11. Exclusion of media hazy eyes if found during the clinical examination (by slit lamp or standard of care)

Design outcomes

Primary

MeasureTime frame
1. Sensitivity of detecting moderate diabetic retinopathy or more severe DR and/or significant macular edema on a person-specific basisTimepoint: Day 1- Evaluation of Fundus photographs by Software and P.I. and comparison of both the results.

Secondary

MeasureTime frame
1. Specificity (true negatives divided by true negatives plus false positives) at detecting more than moderate non proliferative diabetic retinopathy and/or significant macular edema on a person-specific basisTimepoint: Day 1

Countries

India

Contacts

Public ContactDr Devesh Kumar

Think i

drdevesh.kumar@thinki.in9971169602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026